UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002763 |
|---|---|
| Receipt number | R000003129 |
| Scientific Title | Phase II study of Amrubicin in patients with Small-Cell Lung Cancer that is refractory or relapsed within 90 days of completing previous treatment (JCOG0901) |
| Date of disclosure of the study information | 2009/11/13 |
| Last modified on | 2014/02/21 14:31:17 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/11/13 13:34:56 | ||
| 2 | Update | 2010/06/04 14:32:49 | Name of person sending information Name of person sending information |
|
| 3 | Update | 2010/06/04 14:34:06 | Key inclusion criteria |
|
| 4 | Update | 2010/12/09 11:19:23 | Institutions |
|
| 5 | Update | 2011/08/03 12:47:25 | Recruitment status Last follow-up date |
|
| 6 | Update | 2013/03/26 17:15:43 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 7 | Update | 2013/07/29 16:54:46 | Recruitment status Date analysis concluded |
|
| 8 | Update | 2014/02/21 14:31:17 | Publication of results URL related to results and publications Results Results |
